Evidence map›Paper›PMID 22191557›Full record

ArticleJournal of medicinal chemistry2012

Wnt inhibition correlates with human embryonic stem cell cardiomyogenesis: a structure-activity relationship study based on inhibitors for the Wnt response.

Marion Lanier, Dennis Schade, Erik Willems, Masanao Tsuda, Sean Spiering, Jaroslaw Kalisiak, Mark Mercola, John R Cashman

Open access · greenAbstract read
In one paragraph

Article in Journal of medicinal chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Frontiers in pharmacology · 2019
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Marion LanierHuman BioMolecular Research Institute, 5310 Eastgate Mall, San Diego, California 92121-2804, United States. mlanier@hbri.org
Dennis Schade
Erik Willems
Masanao Tsuda
Sean Spiering
Jaroslaw Kalisiak
Mark Mercola
John R Cashman
Sanford Burnham Prebys Medical Discovery Institute · USChemRegen (United States) · USHuman BioMolecular Research Institute · US

Funding

MOLECULAR BIOLOGY OF HEART INDUCTIONR01HL059502 · NHLBI · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI MERCOLA, MARK · 1997 to 2005
$1.4M
Reconstruction & Modeling of Networks Involved in Cardiomyocyte DifferentiationR33HL088266 · NHLBI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI MERCOLA, MARK · 2007 to 2009
$1.0M
NHLBI NIH HHS R01 HL059502NHLBI NIH HHS R01HL059502NHLBI NIH HHS R33 HL088266NHLBI NIH HHS R33HL088266
6 · The paper itself

Abstract

Human embryonic stem cell-based high-content screening of 550 known signal transduction modulators showed that one "lead" (1, a recently described inhibitor of the proteolytic degradation of Axin) stimulated cardiomyogenesis. Because Axin controls canonical Wnt signaling, we conducted an investigation to determine whether the cardiogenic activity of 1 is Wnt-dependent, and we developed a structure-activity relationship to optimize the cardiogenic properties of 1. We prepared analogues with a range of potencies (low nanomolar to inactive) for Wnt/β-catenin inhibition and for cardiogenic induction. Both functional activities correlated positively (r(2) = 0.72). The optimal compounds induced cardiogenesis 1.5-fold greater than 1 at 30-fold lower concentrations. In contrast, no correlation was observed for cardiogenesis and modulation of transforming growth factor β (TGFβ)/Smad signaling that prominently influences cardiogenesis. Taken together, these data show that Wnt signaling inhibition is essential for cardiogenic activity and that the pathway can be targeted for the design of druglike cardiogenic molecules.

Indexed as

Cell DifferentiationCell LineEmbryonic Stem CellsHeterocyclic Compounds, 3-RingHumansMyocytes, CardiacStructure-Activity RelationshipTetrahydronaphthalenesWnt Proteins4-((1,3-dioxooctahydro-2H-4,7-methanoisoindol-2-yl))-N-(8-oxo-5,6,7,8-tetrahydronaphthalen-1-yl)cyclohexylcarboxamideHeterocyclic Compounds, 3-RingTetrahydronaphthalenesWnt Proteins

Identifiers

PMID22191557
PMCPMC3335202
OpenAlexW1983172566

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.